Viewing Study NCT02781727

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2026-02-27 @ 7:06 PM
Study NCT ID: NCT02781727
Status: COMPLETED
Last Update Posted: 2022-01-04
First Post: 2016-05-19
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Sponsor: Ascendis Pharma Endocrinology Division A/S
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Hormone Deficiency, Pediatric View
None hGH (Human Growth Hormone) View
None Endocrine System Diseases View
None Hormones View
None Pituitary Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human Growth Hormone View
None hGH View
None GHD View
None rHGH View
None Pediatric Growth Hormone Deficiency View
None Long Acting Growth Hormone View
None Somatropin View
None Prodrug View
None Growth Failure View
None Growth Hormone Replacement Therapy View
None Sustained Release View
None Sustained Release Growth Hormone View
None Growth Hormone Deficiency View